Cocrystal Pharma Shares Outstanding 2008-2019 | COCP

Cocrystal Pharma shares outstanding from 2008 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Cocrystal Pharma Annual Shares Outstanding
(Millions of Shares)
2018 28
2017 24
2016 24
2015 21
2014 328
2013 57
2012 62
2011 50
2010 45
2009 4
2008 4
2007 3
Cocrystal Pharma Quarterly Shares Outstanding
(Millions of Shares)
Q2 2019 32
Q1 2019 30
Q4 2018 28
Q3 2018 30
Q2 2018 28
Q1 2018 24
Q4 2017 24
Q3 2017 24
Q2 2017 24
Q1 2017 24
Q4 2016 24
Q3 2016 707
Q2 2016 706
Q1 2016 697
Q4 2015 21
Q3 2015 697
Q2 2015 697
Q1 2015 440
Q4 2014 328
Q3 2014 327
Q2 2014 327
Q1 2014 324
Q4 2013 57
Q3 2013 57
Q2 2013 57
Q1 2013 57
Q4 2012 62
Q3 2012 69
Q2 2012 59
Q1 2012 56
Q4 2011 50
Q3 2011 67
Q2 2011 41
Q1 2011 45
Q4 2010 45
Q3 2010 38
Q2 2010 38
Q1 2010 38
Q4 2009 4
Q3 2009 4
Q2 2009 4
Q1 2009 4
Q4 2008 4
Q3 2008 4
Q2 2008 4
Q1 2008 4
Q3 2007 4
Q2 2007 3
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.058B $0.000B
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of HepC. Phase 1b studies in HepC infected patients showed the largest reduction in viral load of any non-nucleoside inhibitor tested to date. The next step for CC-31244 is clinical trials as part of a cocktail for ultra-short therapy of 2 to 6 weeks. The lead candidate for influenza has advanced to IND-enabling studies. It is effective in animal models against both the pandemic and seasonal strains of influenza. In addition, the Company has a pipeline of promising early preclinical programs. Two private investors own approximately 48% of the Company.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.390B 13.26
Gilead Sciences (GILD) United States $83.434B 10.25
CSL (CSLLY) Australia $71.884B 0.00
Celgene (CELG) United States $69.726B 10.79
Vertex Pharmaceuticals (VRTX) United States $45.637B 49.32
Illumina (ILMN) United States $44.231B 51.97
Biogen (BIIB) United States $43.552B 7.74
Regeneron Pharmaceuticals (REGN) United States $31.400B 14.25
Alexion Pharmaceuticals (ALXN) United States $24.338B 12.83
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.848B 49.58
Exact Sciences (EXAS) United States $13.520B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.318B 0.00
Genmab (GNMSF) Denmark $12.400B 69.55
Seattle Genetics (SGEN) United States $11.500B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.427B 0.00
Galapagos (GLPG) Belgium $8.683B 0.00
QIAGEN (QGEN) Netherlands $7.670B 25.19
Bio-Techne Corp (TECH) United States $7.583B 52.39
Guardant Health (GH) United States $6.971B 0.00
Sarepta Therapeutics (SRPT) United States $6.469B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.359B 0.00
BeiGene (BGNE) Cayman Islands $6.268B 0.00
Amarin (AMRN) Ireland $6.162B 0.00
Bluebird Bio (BLUE) United States $5.906B 0.00
Exelixis (EXEL) United States $5.846B 15.20
Moderna (MRNA) United States $5.630B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.894B 0.00
Horizon Pharma Public (HZNP) Ireland $4.850B 12.33
Ascendis Pharma (ASND) Denmark $4.423B 0.00
Repligen (RGEN) United States $4.098B 79.52
Spark Therapeutics (ONCE) United States $4.033B 0.00
Blueprint Medicines (BPMC) United States $3.978B 0.00
China Biologic Products (CBPO) China $3.935B 24.56
Medicines (MDCO) United States $3.864B 0.00
MorphoSys AG (MOR) Germany $3.670B 0.00
Alkermes (ALKS) Ireland $3.587B 0.00
Mirati Therapeutics (MRTX) United States $3.400B 0.00
Immunomedics (IMMU) United States $3.325B 0.00
Emergent Biosolutions (EBS) United States $2.742B 41.19
CRISPR Therapeutics AG (CRSP) Switzerland $2.715B 0.00
Genomic Health (GHDX) United States $2.667B 50.01
Arena Pharmaceuticals (ARNA) United States $2.607B 5.60
Reata Pharmaceuticals (RETA) United States $2.591B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.582B 0.00
Amicus Therapeutics (FOLD) United States $2.503B 0.00
MyoKardia (MYOK) United States $2.461B 0.00
Halozyme Therapeutics (HALO) United States $2.392B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.362B 0.00
Acceleron Pharma (XLRN) United States $2.352B 0.00
NeoGenomics (NEO) United States $2.246B 120.17
Myriad Genetics (MYGN) United States $2.105B 22.09
Akcea Therapeutics (AKCA) United States $2.067B 0.00
Cambrex (CBM) United States $2.004B 25.33
Zai Lab (ZLAB) China $1.990B 0.00
Ligand Pharmaceuticals (LGND) United States $1.937B 24.49
Denali Therapeutics (DNLI) United States $1.891B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.863B 0.00
UniQure (QURE) Netherlands $1.776B 0.00
Insmed (INSM) United States $1.701B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.547B 0.00
REGENXBIO (RGNX) United States $1.470B 0.00
Coherus BioSciences (CHRS) United States $1.446B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.389B 0.00
Alector (ALEC) United States $1.333B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.331B 0.00
Sangamo Therapeutics (SGMO) United States $1.307B 0.00
Editas Medicine (EDIT) United States $1.275B 0.00
AnaptysBio (ANAB) United States $1.224B 0.00
Fate Therapeutics (FATE) United States $1.183B 0.00
Innoviva (INVA) United States $1.168B 3.37
RA PHARMCTL INC (RARX) United States $1.162B 0.00
Epizyme (EPZM) United States $1.110B 0.00
Athenex (ATNX) United States $1.053B 0.00
Zymeworks (ZYME) Canada $1.014B 0.00
Twist Bioscience (TWST) United States $0.986B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Cara Therapeutics (CARA) United States $0.949B 0.00
WAVE Life Sciences (WVE) Singapore $0.939B 0.00
ANI Pharmaceuticals (ANIP) United States $0.881B 14.72
Codexis (CDXS) United States $0.861B 0.00
Arvinas (ARVN) United States $0.845B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Principia Biopharma (PRNB) United States $0.823B 429.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.769B 0.00
Cytokineticsorporated (CYTK) United States $0.763B 0.00
Anika Therapeutics (ANIK) United States $0.748B 26.47
Zealand Pharma (ZEAL) Denmark $0.745B 8.64
Vanda Pharmaceuticals (VNDA) United States $0.727B 26.25
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Intellia Therapeutics (NTLA) United States $0.716B 0.00
Vericel (VCEL) United States $0.711B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Mesoblast (MESO) Australia $0.699B 0.00
MiMedx (MDXG) United States $0.597B 0.00
DBV Technologies S.A (DBVT) France $0.591B 0.00
Revance Therapeutics (RVNC) United States $0.590B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.552B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.546B 0.00
Intra-Cellular Therapies (ITCI) United States $0.540B 0.00
Cellectis S.A (CLLS) France $0.539B 0.00
Heska (HSKA) United States $0.539B 69.82
Retrophin (RTRX) United States $0.529B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
UROGEN PHARMA (URGN) United States $0.495B 0.00
Precision BioSciences (DTIL) United States $0.489B 0.00
Syros Pharmaceuticals (SYRS) United States $0.487B 0.00
Stemline Therapeutics (STML) United States $0.480B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Puma Biotechnology (PBYI) United States $0.458B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.448B 0.00
BioDelivery Sciences (BDSI) United States $0.433B 0.00
Arcus Biosciences (RCUS) United States $0.431B 0.00
CytomX Therapeutics (CTMX) United States $0.420B 0.00
Agenus (AGEN) United States $0.411B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.410B 0.00
Adverum Biotechnologies (ADVM) United States $0.405B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
Protagonist Therapeutics (PTGX) United States $0.379B 0.00
Merus (MRUS) Netherlands $0.379B 0.00
AC Immune SA (ACIU) Switzerland $0.366B 27.05
Gritstone Oncology (GRTS) United States $0.352B 0.00
Kadmon Holdings (KDMN) United States $0.351B 0.00
Prothena (PRTA) Ireland $0.351B 0.00
Scholar Rock Holding (SRRK) United States $0.348B 0.00
Theratechnologies (THERF) Canada $0.346B 0.00
Kindred Biosciences (KIN) United States $0.331B 0.00
Albireo Pharma (ALBO) United States $0.327B 0.00
Biofrontera AG (BFRA) Germany $0.324B 483.33
Avid Bioservices (CDMO) United States $0.319B 0.00
Cel-Sci (CVM) United States $0.317B 0.00
Sorrento Therapeutics (SRNE) United States $0.316B 0.00
Clovis Oncology (CLVS) United States $0.309B 0.00
Pfenex (PFNX) United States $0.307B 0.00
ADMA Biologics Inc (ADMA) United States $0.304B 0.00
Dynavax Technologies (DVAX) United States $0.296B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.291B 0.00
Geron (GERN) United States $0.286B 0.00
Cellular Biomedicine (CBMG) United States $0.286B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.270B 0.00
Inovio Pharmaceuticals (INO) United States $0.266B 0.00
MannKind (MNKD) United States $0.265B 0.00
PDL BioPharma (PDLI) United States $0.262B 6.74
Senesco Technologies (ELOX) United States $0.258B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
ChromaDex (CDXC) United States $0.256B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.252B 0.00
Sutro Biopharma (STRO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.243B 0.00
Palatin Technologies (PTN) United States $0.243B 7.13
Prometic Life Sciences (PFSCF) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.237B 0.00
Spero Therapeutics (SPRO) United States $0.230B 0.00
Athersys (ATHX) United States $0.226B 0.00
Compugen (CGEN) Israel $0.217B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Five Prime Therapeutics (FPRX) United States $0.208B 0.00
Kamada (KMDA) Israel $0.207B 7.91
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.202B 0.00
Cue Biopharma (CUE) United States $0.201B 0.00
EXICURE INC (XCUR) United States $0.199B 0.00
OSMOTICA PHARM (OSMT) United States $0.198B 0.00
CorMedix Inc (CRMD) United States $0.197B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.188B 0.00
Novavax (NVAX) United States $0.181B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.180B 0.00
Enzo Biochem (ENZ) United States $0.173B 0.00
Arsanis (XFOR) United States $0.173B 0.00
Acorda Therapeutics (ACOR) United States $0.172B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.167B 0.00
Emmaus Life Sciences (EMMA) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
XOMA (XOMA) United States $0.164B 0.00
Nicox SA (NICXF) France $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.159B 0.00
Dyadic (DYAI) United States $0.155B 0.00
Alcobra (ARCT) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.153B 6.29
BioTime (LCTX) United States $0.151B 10.10
Cerecor (CERC) United States $0.149B 0.00
Abeona Therapeutics (ABEO) United States $0.147B 0.00
Northwest Biotherapeutics (NWBO) United States $0.147B 0.00
PHASEBIO PHARMA (PHAS) United States $0.144B 0.00
Adocia (ADOCY) France $0.140B 0.00
Aptinyx (APTX) United States $0.136B 0.00
Fortress Biotech (FBIO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
NantKwest (NK) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
Verastem (VSTM) United States $0.102B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.100B 0.00
Celyad SA (CYAD) Belgium $0.100B 0.00
Checkpoint Therapeutics (CKPT) United States $0.100B 0.00
Arbutus Biopharma (ABUS) Canada $0.096B 0.00
VTv Therapeutics (VTVT) United States $0.096B 0.00
Trevena (TRVN) United States $0.092B 0.00
Mersana Therapeutics (MRSN) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.090B 0.00
OvaScience (MLND) United States $0.090B 0.00
Idera Pharmaceuticals (IDRA) United States $0.090B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.083B 0.00
Selecta Biosciences (SELB) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.075B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
NewLink Genetics (NLNK) United States $0.072B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
VBI Vaccines (VBIV) United States $0.072B 0.00
Curis (CRIS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.070B 38.50
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
ARAVIVE, INC (ARAV) United States $0.066B 0.00
Unum Therapeutics (UMRX) United States $0.063B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Prima BioMed (IMMP) Australia $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
AIT Therapeutics (XAIR) United States $0.052B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Ophthotech (ISEE) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VIVUS (VVUS) United States $0.046B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.042B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.034B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.77
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.023B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00